[Clinical study of a new protocol on the termination of early pregnancy by administration of dl-15-methyl prostaglandin F2 alpha in combination with testosterone propionate].
Zhou
Y F
YF
D000028:Abortion, Induced; D000728:Androgens; D001695:Biology; D002264:Carboxylic Acids; D055598:Chemical Phenomena; D002621:Chemistry; D003267:Contraception; D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D003274:Contraceptive Devices, Female; D004703:Endocrine System; D005193:Family Planning Services; D006728:Hormones; D009930:Organic Chemicals; D010570:Pessaries; D010827:Physiology; D011247:Pregnancy; D011261:Pregnancy Trimester, First; D011453:Prostaglandins; D012098:Reproduction; D012102:Reproductive Control Agents; D012106:Research; D013089:Spermatocidal Agents; D013739:Testosterone
D000728:Androgens; D002264:Carboxylic Acids; D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D006728:Hormones; D009930:Organic Chemicals; D011453:Prostaglandins; D012102:Reproductive Control Agents; D013089:Spermatocidal Agents; D013739:Testosterone
Abortion, Induced; Androgens; Barrier Methods; Biology; Carboxylic Acids; Clinical Research; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptive Methods; Endocrine System; Family Planning; Fertility Control, Postconception; Hormones; Ingredients And Chemicals; Organic Chemicals; Physiology; Pregnancy; Pregnancy, First Trimester; Prostaglandins--administraction and dosage; Prostaglandins--side effects; Reproduction; Reproductive Control Agents; Research Methodology; Spermicidal Contraceptive Agents; Testosterone--administraction and dosage; Vaginal Barrier Methods; Vaginal Spermicides; Vaginal Sponge; Vaginal Suppository